This Article Full Text Full Text (PDF) All Versions of this Article: 45/5/1004    most recent 01.HYP.0000161995.64192.2bv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Qi, N. R. Articles by Kurtz, T. W. Search for Related Content PubMed PubMed Citation Articles by Qi, N. R. Articles by Kurtz, T. W. Related Collections Animal models of human disease Hypertension - basic studies Type 2 diabetes Glucose intolerance

(Hypertension. 2005;45:1004.)
© 2005 American Heart Association, Inc.

Original Articles

A New Transgenic Rat Model of Hepatic Steatosis and the Metabolic Syndrome

Nathan R. Qi; Jiaming Wang; Vaclav Zidek; Vladimir Landa; Petr Mlejnek; Ludmila Kazdová; Michal Pravenec; Theodore W. Kurtz

From the Department of Laboratory Medicine (N.Q., J.W., T.W.K.), University of California, San Francisco; Institute of Physiology (V.Z., V.L., P.M., M.P.), Czech Academy of Sciences and the Center for Applied Genomics, Prague, Czech Republic; and the Institute for Clinical and Experimental Medicine (L.K.), Prague, Czech Republic.

Correspondence to Theodore W. Kurtz, MD, Professor of Laboratory Medicine, UCSF Clinical Laboratories, 185 Berry Street, Suite 290, San Francisco, CA 94107. E-mail KurtzT{at}Labmed2.ucsf.edu

Fatty liver is extremely common in insulin-resistant patients with either obesity or lipodystrophy and it has been proposed that hepatic steatosis be considered an additional feature of the metabolic syndrome. Although insulin resistance can promote fatty liver, excessive hepatic accumulation of fat can also promote insulin resistance and could contribute to the pathogenesis of the metabolic syndrome. We sought to create a new nonobese rat model with hypertension, hepatic steatosis, and the metabolic syndrome by transgenic overexpression of a sterol-regulatory element-binding protein (SREBP-1a) in the spontaneously hypertensive rat (SHR). SREBPs are transcription factors that activate the expression of multiple genes involved in the hepatic synthesis of cholesterol, triglycerides, and fatty acids. The new transgenic strain of SHR overexpressing a dominant-positive form of human SREBP-1a under control of the phosphoenolpyruvate carboxykinase (PEPCK) promoter exhibited marked hepatic steatosis with major biochemical features of the metabolic syndrome, including hyperglycemia, hyperinsulinemia, and hypertriglyceridemia. Both oxidative and nonoxidative skeletal muscle glucose metabolism were significantly impaired in the SHR transgenic strain and glucose tolerance deteriorated as the animals aged. The SHR transgenic strain also exhibited reduced body weight and reduced adipose tissue stores; however, the level of hypertension in the transgenic SHR was similar to that in the nontransgenic SHR control. The transgenic SHR overexpressing SREBP-1a represents a nonobese rat model of fatty liver, disordered glucose and lipid metabolism, and hypertension that may provide new opportunities for studying the pathogenesis and treatment of the metabolic syndrome associated with hepatic steatosis.

Key Words: hypertension • insulin resistance • liver • metabolism • rats • transcription, genetic

This article has been cited by other articles:

				J. Koska, N. Stefan, P. A Permana, C. Weyer, M. Sonoda, C. Bogardus, S. R Smith, D. R Joanisse, T. Funahashi, J. Krakoff, et al. Increased fat accumulation in liver may link insulin resistance with subcutaneous abdominal adipocyte enlargement, visceral adiposity, and hypoadiponectinemia in obese individuals Am. J. Clinical Nutrition, February 1, 2008; 87(2): 295 - 302. [Abstract] [Full Text] [PDF]

				A. Kallin, L. E. Johannessen, P. D. Cani, C. Y. Marbehant, A. Essaghir, F. Foufelle, P. Ferre, C.-H. Heldin, N. M. Delzenne, and J.-B. Demoulin SREBP-1 regulates the expression of heme oxygenase 1 and the phosphatidylinositol-3 kinase regulatory subunit p55{gamma} J. Lipid Res., July 1, 2007; 48(7): 1628 - 1636. [Abstract] [Full Text] [PDF]

				M. Pravenec and T. W. Kurtz Molecular Genetics of Experimental Hypertension and the Metabolic Syndrome: From Gene Pathways to New Therapies Hypertension, May 1, 2007; 49(5): 941 - 952. [Abstract] [Full Text] [PDF]

				K. Sugimoto, N. R. Qi, L. Kazdova, M. Pravenec, T. Ogihara, and T. W. Kurtz Telmisartan But Not Valsartan Increases Caloric Expenditure and Protects Against Weight Gain and Hepatic Steatosis Hypertension, May 1, 2006; 47(5): 1003 - 1009. [Abstract] [Full Text] [PDF]